Literature DB >> 9156126

The significance of arterial hypertension at the onset of clinical lupus nephritis.

I P Naiker1, V Chrystal, I G Randeree, Y K Seedat.   

Abstract

The prognostic importance of hypertension at the onset of clinical lupus nephritis is not well established. We studied retrospectively 44 patients with lupus nephritis in order to ascertain the prevalence of hypertension at presentation and to investigate a possible association between hypertension and renal functional impairment. A correlation was also sought between hypertension and histological class of lupus nephritis. Hypertension was graded as mild (diastolic 95-99 mmHg), moderate (100-114) or severe (> 115). Impaired renal function (creatinine > 120 mumol/l) was graded as mild (120-200 mumol/l), moderate (200-350 mumol/l), or severe (> 350 mumol/l). Histological class and the presence of hypertensive renal vascular lesions was recorded. The prevalence of hypertension was 38%. There were 17 hypertensives and 27 normotensives. The incidence of renal impairment was greater in the hypertensives, 47% vs 18.5% (p = 0.04). Mean serum creatinine was also higher higher in this group (p = 0.02). The presence of hypertensive renal vascular lesions identified a high-risk subgroup who had a higher incidence of renal functional impairment and worse renal function than the hypertensive group as a whole. Even at an early stage, hypertension and hypertensive renal vascular lesions correlated well with renal functional impairment. Aggressive treatment of hypertension is therefore essential in early lupus nephritis in order to prevent further deterioration of renal function as the disease evolves.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9156126      PMCID: PMC2431293          DOI: 10.1136/pgmj.73.858.230

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  21 in total

1.  Autoimmune disease and parasitic infections in Nigerians.

Authors:  B M Greenwood
Journal:  Lancet       Date:  1968-08-17       Impact factor: 79.321

2.  Evaluation of clearance studies in lupus nephritis.

Authors:  J L Rosenbaum; M Akhtar; M S Kramer; R M Raja; R Manchanda; N Lazaro
Journal:  Clin Nephrol       Date:  1974       Impact factor: 0.975

3.  Systemic lupus erythematosus in Cape Town.

Authors:  S Jessop; O L Meyers
Journal:  S Afr Med J       Date:  1973-02-10

4.  Race, environment and blood pressure: the South African experience.

Authors:  Y K Seedat
Journal:  J Hypertens       Date:  1983-06       Impact factor: 4.844

5.  The clinical course of the proliferative and membranous forms of lupus nephritis.

Authors:  D S Baldwin; J Lowenstein; N F Rothfield; G Gallo; R T McCluskey
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

6.  Hypertension and renal disease in systemic lupus erythematosus.

Authors:  D R Budman; A D Steinberg
Journal:  Arch Intern Med       Date:  1976-09

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Systemic lupus erythematosus in Zimbabwe.

Authors:  H G Taylor; C M Stein
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

9.  Lupus nephritis. Clinical course as related to morphologic forms and their transitions.

Authors:  D S Baldwin; M C Gluck; J Lowenstein; G R Gallo
Journal:  Am J Med       Date:  1977-01       Impact factor: 4.965

10.  Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.

Authors:  H A Austin; L R Muenz; K M Joyce; T T Antonovych; J E Balow
Journal:  Kidney Int       Date:  1984-04       Impact factor: 10.612

View more
  7 in total

Review 1.  Lupus nephritis in Colombians: contrasts and comparisons with other populations.

Authors:  Juan-Manuel Anaya; Carlos Cañas; Rubén D Mantilla; Ricardo Pineda-Tamayo; Gabriel J Tobón; Catalina Herrera-Diaz; Diego M Rendón; Adriana Rojas-Villarraga; Mauricio Uribe
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

2.  Cyclophosphamide therapy for lupus nephritis: poor renal survival in Arab children.

Authors:  Abdullah A Al Salloum
Journal:  Pediatr Nephrol       Date:  2003-03-28       Impact factor: 3.714

3.  Chronic kidney disease in Korean patients with lupus nephritis: over a 35-year period at a single center.

Authors:  Howook Jeon; Jennifer Lee; Ji Hyeon Ju; Wan-Uk Kim; Sung-Hwan Park; Su-Jin Moon; Seung-Ki Kwok
Journal:  Clin Rheumatol       Date:  2022-02-18       Impact factor: 2.980

Review 4.  Estrogen in cardiovascular disease during systemic lupus erythematosus.

Authors:  Emily L Gilbert; Michael J Ryan
Journal:  Clin Ther       Date:  2014-09-04       Impact factor: 3.393

5.  A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach.

Authors:  John G Hanly; Li Su; Murray B Urowitz; Juanita Romero-Diaz; Caroline Gordon; Sang-Cheol Bae; Sasha Bernatsky; Ann E Clarke; Daniel J Wallace; Joan T Merrill; David A Isenberg; Anisur Rahman; Ellen M Ginzler; Michelle Petri; Ian N Bruce; M A Dooley; Paul Fortin; Dafna D Gladman; Jorge Sanchez-Guerrero; Kristjan Steinsson; Rosalind Ramsey-Goldman; Munther A Khamashta; Cynthia Aranow; Graciela S Alarcón; Barri J Fessler; Susan Manzi; Ola Nived; Gunnar K Sturfelt; Asad A Zoma; Ronald F van Vollenhoven; Manuel Ramos-Casals; Guillermo Ruiz-Irastorza; S Sam Lim; Kenneth C Kalunian; Murat Inanc; Diane L Kamen; Christine A Peschken; Soren Jacobsen; Anca Askanase; Chris Theriault; Vernon Farewell
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

6.  Good Long-Term Prognosis of Lupus Nephritis in the High-Income Afro-Caribbean Population of Martinique with Free Access to Healthcare.

Authors:  Benoit Suzon; Fabienne Louis-Sidney; Cédric Aglaé; Kim Henry; Cécile Bagoée; Sophie Wolff; Florence Moinet; Violaine Emal-Aglaé; Katlyne Polomat; Michel DeBandt; Christophe Deligny; Aymeric Couturier
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

7.  The frequency and outcome of lupus nephritis: results from an international inception cohort study.

Authors:  John G Hanly; Aidan G O'Keeffe; Li Su; Murray B Urowitz; Juanita Romero-Diaz; Caroline Gordon; Sang-Cheol Bae; Sasha Bernatsky; Ann E Clarke; Daniel J Wallace; Joan T Merrill; David A Isenberg; Anisur Rahman; Ellen M Ginzler; Paul Fortin; Dafna D Gladman; Jorge Sanchez-Guerrero; Michelle Petri; Ian N Bruce; Mary Anne Dooley; Rosalind Ramsey-Goldman; Cynthia Aranow; Graciela S Alarcón; Barri J Fessler; Kristjan Steinsson; Ola Nived; Gunnar K Sturfelt; Susan Manzi; Munther A Khamashta; Ronald F van Vollenhoven; Asad A Zoma; Manuel Ramos-Casals; Guillermo Ruiz-Irastorza; S Sam Lim; Thomas Stoll; Murat Inanc; Kenneth C Kalunian; Diane L Kamen; Peter Maddison; Christine A Peschken; Soren Jacobsen; Anca Askanase; Chris Theriault; Kara Thompson; Vernon Farewell
Journal:  Rheumatology (Oxford)       Date:  2015-09-05       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.